Basics |
Beam Therapeutics Inc.
|
IPO Date: |
February 6, 2020 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$1.83B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$1.62 | 3.52%
|
Avg Daily Range (30 D): |
$0.90 | 4.79%
|
Avg Daily Range (90 D): |
$0.94 | 3.94%
|
Institutional Daily Volume |
Avg Daily Volume: |
.86M |
Avg Daily Volume (30 D): |
2.28M |
Avg Daily Volume (90 D): |
1.59M |
Trade Size |
Avg Trade Size (Sh.): |
57 |
Avg Trade Size (Sh.) (30 D): |
76 |
Avg Trade Size (Sh.) (90 D): |
66 |
Institutional Trades |
Total Inst.Trades: |
2,882 |
Avg Inst. Trade: |
$3.16M |
Avg Inst. Trade (30 D): |
$2.99M |
Avg Inst. Trade (90 D): |
$2.98M |
Avg Inst. Trade Volume: |
.08M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$4.89M |
Avg Closing Trade (30 D): |
$5.22M |
Avg Closing Trade (90 D): |
$5.6M |
Avg Closing Volume: |
128.34K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-4.58
|
$-1.09
|
$-4.58
|
Diluted EPS
|
$-4.58
|
$-1.09
|
$-4.58
|
Revenue
|
$ 63.52M
|
$ 30.07M
|
$ 63.52M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -376.74M
|
$ -90.35M
|
$ -376.74M
|
Operating Income / Loss
|
$ -415.57M
|
$ -100.04M
|
$ -415.57M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -154.5M
|
$ 53.36M
|
$ -154.5M
|
PE Ratio
|
|
|
|
|